RaDaR MRD testing is validated for use in multiple solid tumor cancers
BREAST CANCER
COLORECTAL CANCER
LUNG CANCER
HEAD & NECK CANCER
RaDaR is a personalized test for minimal residual disease (MRD) and recurrence detection

RaDaR has been carefully designed to detect tumor DNA in the blood with exceptional sensitivity and specificity
- Increased accuracy with a tumor-informed, personalized panel design: RaDaR sequencing assays monitor up to 48 tumor-specific mutations, unique to each patient’s tumor, to help detect circulating tumor DNA (ctDNA)
- Earlier detection with high sensitivity: RaDaR can detect extremely low levels of ctDNA in the blood, with a demonstrated LoD95 = 0.001% VAF. This can give additional time for important treatment management decisions
- Fewer false positives with high specificity: RaDaR has a demonstrated analytical specificity of 100% in validation studies for more reliable results
NeoGenomics has been supporting oncologists and pathologists in their goal to provide patients with the best care possible since 2002.
LoD95 = limit of detection, working at a confidence of 95%; VAF = variant allele fraction.
How does RaDaR work?
STEP 1
Send in a patient’s formalin-fixed paraffin-embedded (FFPE) tumor sample to the NeoGenomics laboratory
STEP 2
Patient’s tumor DNA is sequenced to determine their tumor’s unique mutation profile
STEP 3
A personalized RaDaR panel is designed for the patient
STEP 4
After initial panel design, ctDNA is tested using blood samples and the patient’s custom RaDaR panel
STEP 5
Report is generated
How to order a RaDaR test

CLIENT SERVICES
NeoGenomics prides itself on its unparalleled customer support team. If you have questions regarding test information, specimen requirements, turnaround times, test add-on, and test results, please feel free to reach out to a Client Services Advocate at client.services@neogenomics.com or call 866.776.5907, option 3.

ONLINE ORDERING
Online Ordering streamlines and simplifies your test-ordering process into a single time-saving, easy-to-use experience.

PAPER ORDER FORMS
Complete a RaDaR test requisition form.
New to NeoGenomics? Call the NeoGenomics Client Services team at 866.776.5907 and press 3 to set up an account.
* The analytical validation study of RaDaR demonstrates a limit of detection (LoD95) of 0.001% variant allele fraction (VAF) with 100% specificity.
References: 1. Tie J, et al. Sci Transl Med. 2016;8(346):346ra92. doi:10.1126/scitranslmed.aaf6219. 2. Chakrabarti S, et al. Cancers. 2020;12(10):2808-2826. 3. Dasari A, Nat Rev Clin Oncol. 2020;17:757-770.
Investigator-Initiated Trials
NeoGenomics recognizes the important role of externally driven scientific research to expand medical knowledge and define the clinical utility of our tests in a real-world setting.
Get started with RaDaR
Contact us to order a RaDaR test.